Friday, June 21, 2024

UpToDate Lexidrug News and Enhancements – June 2024

 

Wolters Kluwer Logo

 

 

 

UpToDate Lexidrug Updates

 

June 2024

 

Mobile and desktop view of Lexidrug

 

At Wolters Kluwer, we are committed to continuous enhancements and innovations — in content, features, and technology. Check out the most recent UpToDate® Lexidrug™ updates, designed to help improve clarity in treatment decisions and answer your clinical questions quickly. Please feel free to share this newsletter with your colleagues!

In this issue: 

  • The UpToDate suite of solutions
  • Tips and tricks: International Brand Names
  • Internet Explorer 11 (IE11) retirement reminder
  • Recent FDA approvals
  • Wolters Kluwer Health in the news
  • Over-the-counter (OTC) birth control pills: Improving access and reducing barriers

 

The UpToDate suite of solutions

As a reminder, we have unified market-leading solutions Lexicomp® and Emmi® under the UpToDate brand to create a fully harmonized suite of offerings for health systems, and to support care teams and patients across the ecosystem.


UpToDate® Lexidrug™, formerly Lexicomp, will continue to deliver the referential drug content you trust to make the best possible evidence-based medication decisions.

 

 

 

 

Tips and tricks: International Brand Names

To help make it easier to verify medicines, accurately prescribe them, and improve patient safety, Lexidrug includes more than 500,000 international brand names from 150+ countries to its extensive international drug brand name database. An enhanced search functionality is available within the Brand Names: International field in Lexidrug monographs for easy access to the expanded list of international brand names.

 

 

 

 

Internet Explorer 11 (IE11) retirement reminder

We will be making security enhancements to UpToDate® Lexidrug™ platforms consistent with the changes Microsoft has made to discontinue support of IE11.


As of June 20, 2024, we have ended support of IE11 for Lexidrug. To ensure an optimal user experience, please transition to using a supported browser, including the latest versions of Edge, Chrome, Firefox, and Safari.


Please contact your IT department if you need help with the transition to a new browser.

 

 

 

Image

Stay updated on recently approved drugs

Be sure to check out the "New FDA Drug Approvals" section on the Lexidrug homepage. Recent approvals include:

Explore Full List

 

 

 

Image

 

Wolters Kluwer Health in the news


Forbes | How Enterprise Analytics Can Help Future-Proof Health Systems

Greg Samios, President and CEO of the Clinical Effectiveness business at Wolters Kluwer, discusses "How Enterprise Analytics Can Help Future-Proof Health Systems" for Forbes.

 

 

Fierce Healthcare | Walmart's exit from health centers reflects broader challenges in primary care

Chief Medical Officer, Dr. Peter Bonis shares his thoughts on the future of retail-based healthcare for Fierce Healthcare.

 

 

HIT Like a Girl Pod | Empowering Healthcare: A Dive into Clinical Decision Support

Julie Frey, VP of Product Management, joins the HIT Like a Girl Pod to chat about Wolters Kluwer's role in healthcare, focusing on clinical decision support tools like UpToDate.

 

 

 

 

 

 

Over-the-counter (OTC) birth control pills: Improving access and reducing barriers

Clinicians play a major role in helping patients understand the safety, availability, and benefits of OTC birth control—and the impact to contraception access is significant.

 

 

 

 

Resources

 

Image

Expert Insights

Get deep domain expertise and information that accelerates decision making.

Read More

Image

Help & Training

Learn more about Lexidrug from our User Academy and Knowledge Base.

See All Resources

Image

Lexidrug On-The-Go

The Lexidrug mobile app is available for clinicians to download (at subscribing organizations).

Learn More

No comments:

Post a Comment